Literature DB >> 36152083

Representation of adults with rheumatoid arthritis in US-based randomized controlled exercise trials: a systematic review with meta-analysis.

George A Kelley1, Kristi S Kelley2.   

Abstract

The purpose of this study was to conduct a systematic review with meta-analysis to determine the representation of adults with rheumatoid arthritis (RA) according to sex, race, and ethnicity in exercise randomized controlled trials (RCTs) conducted in the USA. Exercise RCTs ≥ 4 weeks conducted in the USA in adults ≥ 18 years with RA were eligible. Studies were retrieved by searching six electronic databases, cross-referencing and searching a clinical trials registry. Dual, independent, study selection and data abstraction were conducted. The primary outcomes were the proportion of participants in each study according to sex as well as race/ethnicity. Results were pooled meta-analytically using the inverse-variance heterogeneity (IVhet) model after applying the double-arcsine transformation. Of the 1030 unique articles screened, five RCTs representing 353 participants with RA were included. The pooled participant prevalence was 83% (95% CI = 73 to 92%) for women and 17% (95% CI = 8 to 27%) for men, suggesting an over-representation of women and an under-representation of men by approximately 7.4% based on current prevalence US estimates for each. Qualitative examination for race and ethnicity demonstrated an under-representation of racial/ethnic minority groups. There is a lack of representation of men with RA in US-based randomized controlled exercise intervention studies. Additional US-based randomized controlled exercise trials, including greater inclusion and reporting of the racial/ethnic composition of participants, are also needed. Key Points • This systematic review with meta-analysis of US studies found an under-representation of men in randomized controlled trials examining the effects of exercise in those with rheumatoid arthritis (RA). • Qualitative examination according to race/ethnicity found both a lack of reporting as well as under-representation of selected racial/ethnic minorities in US-based randomized controlled exercise studies among adults with RA. • This study highlights the need for additional US-based randomized controlled trials of exercise in adults with RA that better represent the RA population in the USA.
© 2022. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).

Entities:  

Keywords:  Exercise; Meta-analysis; Race/ethnicity; Rheumatoid arthritis; Sex; Systematic review

Year:  2022        PMID: 36152083     DOI: 10.1007/s10067-022-06360-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  41 in total

Review 1.  The role of exercise in the management of rheumatoid arthritis.

Authors:  George S Metsios; Antonis Stavropoulos-Kalinoglou; George D Kitas
Journal:  Expert Rev Clin Immunol       Date:  2015-07-15       Impact factor: 4.473

2.  A pilot study to determine whether disability and disease activity are different in African-American and Caucasian patients with rheumatoid arthritis in St. Louis, Missouri, USA.

Authors:  Ulker Tok Iren; Mark S Walker; Eric Hochman; Richard Brasington
Journal:  J Rheumatol       Date:  2005-04       Impact factor: 4.666

3.  Societal cost of rheumatoid arthritis patients in the US.

Authors:  Howard Birnbaum; Crystal Pike; Rebecca Kaufman; Maryna Marynchenko; Yohanne Kidolezi; Mary Cifaldi
Journal:  Curr Med Res Opin       Date:  2010-01       Impact factor: 2.580

4.  Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I.

Authors:  Charles G Helmick; David T Felson; Reva C Lawrence; Sherine Gabriel; Rosemarie Hirsch; C Kent Kwoh; Matthew H Liang; Hilal Maradit Kremers; Maureen D Mayes; Peter A Merkel; Stanley R Pillemer; John D Reveille; John H Stone
Journal:  Arthritis Rheum       Date:  2008-01

5.  Health status disparities in ethnic minority patients with rheumatoid arthritis: a cross-sectional study.

Authors:  Bonnie Bruce; James F Fries; Kirsten Naumann Murtagh
Journal:  J Rheumatol       Date:  2007-06-01       Impact factor: 4.666

6.  Racial and ethnic disparities in disease activity in patients with rheumatoid arthritis.

Authors:  Jeffrey D Greenberg; Tanya M Spruill; Ying Shan; George Reed; Joel M Kremer; Jeffrey Potter; Yusuf Yazici; Gbenga Ogedegbe; Leslie R Harrold
Journal:  Am J Med       Date:  2013-12       Impact factor: 4.965

7.  Mortality in patients with rheumatoid arthritis: a 15-year prospective cohort study.

Authors:  J van den Hoek; H C Boshuizen; L D Roorda; G J Tijhuis; M T Nurmohamed; G A M van den Bos; J Dekker
Journal:  Rheumatol Int       Date:  2016-12-28       Impact factor: 2.631

Review 8.  Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies.

Authors:  Qiang Guo; Yuxiang Wang; Dan Xu; Johannes Nossent; Nathan J Pavlos; Jiake Xu
Journal:  Bone Res       Date:  2018-04-27       Impact factor: 13.567

9.  Demographic Characteristics of Participants in Rheumatoid Arthritis Randomized Clinical Trials: A Systematic Review.

Authors:  Adrienne Strait; Francine Castillo; Sonam Choden; Jing Li; Evans Whitaker; Titilola Falasinnu; Gabriela Schmajuk; Jinoos Yazdany
Journal:  JAMA Netw Open       Date:  2019-11-01

10.  Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study.

Authors:  Tuulikki Sokka; Sergio Toloza; Maurizio Cutolo; Hannu Kautiainen; Heidi Makinen; Feride Gogus; Vlado Skakic; Humeira Badsha; Tõnu Peets; Asta Baranauskaite; Pál Géher; Ilona Ujfalussy; Fotini N Skopouli; Maria Mavrommati; Rieke Alten; Christof Pohl; Jean Sibilia; Andrea Stancati; Fausto Salaffi; Wojciech Romanowski; Danuta Zarowny-Wierzbinska; Dan Henrohn; Barry Bresnihan; Patricia Minnock; Lene Surland Knudsen; Johannes Wg Jacobs; Jaime Calvo-Alen; Juris Lazovskis; Geraldo da Rocha Castelar Pinheiro; Dmitry Karateev; Daina Andersone; Sylejman Rexhepi; Yusuf Yazici; Theodore Pincus
Journal:  Arthritis Res Ther       Date:  2009-01-14       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.